Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia

Schizophrenia Research

Volumn 53, Issue 3, 2002, Pages 249-261

  Schuepbach, Daniel ^a,b   Keshavan, Matcheri S ^a   Kmiec, Julie A ^a   Sweeney, John A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cognitive function; First episode schizophrenia; Symptoms of schizophrenia

Indexed keywords

HALOPERIDOL; RISPERIDONE;

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CONVALESCENCE; DISEASE COURSE; FEMALE; HUMAN; LANGUAGE; LEARNING; MALE; MENTAL PERFORMANCE; MOTOR ACTIVITY; NEGATIVE SYNDROME; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT OUTCOME; VERBAL BEHAVIOR;

ACUTE DISEASE; ADULT; AFFECT; COGNITION DISORDERS; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 0037079826     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00195-5     Document Type: Article

References (38)

1. Cognitive functioning and positive and negative symptoms in schizophrenia
2. Neuropsychological impairment in first-episode and chronic schizophrenic patients
3. The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and theoretical foundations
4. Methods for assessing positive and negative symptoms
5. Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia
6. Visual perception of line direction in patients with unilateral brain disease
7. Neuropsychology of first-episode schizophrenia: Initial characterization and clinical correlates
8. Neurocognitive impairment in schizophrenia and how it affects treatment options
9. Structural neuroimaging and neuropsychological impairments
10. The prediction of outcome in schizophrenia IV: Eleven-year follow-up of the Washington IPSS Cohort
11. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: A longitudinal study
12. Antipsychotic drug: Clinical pharmacology and therapeutic use
13. Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia
14. Cognitive dysfunction in schizophrenia: A new set of tools for the assessment of cognition and drug effects
15. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia
16. Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
17. Meta-analysis of symptom factors in schizophrenia
18. Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia
19. Neuropsychological functioning of first-episode schizophreniform patients
20. First-episode schizophrenia: The importance of early intervention and subjective tolerability
21. Time course of antipsychotic effects of neuroleptic drugs
22. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis
23. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia
24. Differences in the EEG profiles of early and late responders to antipsychotic treatment in first-episode, drug-naive psychotic patients
25. Neuropsychological functioning in first-episode psychosis - Evidence of specific deficits
26. Cognitive deficits and cognitive training in schizophrenic patients: A review
27. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia
28. Abnormalities of the left temporal lobe and thought disorder in schizophrenia: A quantitative magnetic resonance imaging study
29. Evaluation of the stability of neuropsychological functioning after acute episodes of schizophrenia: One-year follow-up study